177Lu-PSMA-617 versus docetaxel in chemotherapy-naïve metastatic castration-resistant prostate cancer: a randomized, controlled, phase 2 non-inferiority trial.
Swayamjeet SatapathyBhagwant Rai MittalAshwani SoodChandan Krushna DasRavimohan Suryanarayan MavuduruShikha GoyalJaya ShuklaShrawan Kumar SinghPublished in: European journal of nuclear medicine and molecular imaging (2021)
Clinical Trials Registry-India, CTRI/2019/12/022282.